These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 17471950)
21. MeInfoText: associated gene methylation and cancer information from text mining. Fang YC; Huang HC; Juan HF BMC Bioinformatics; 2008 Jan; 9():22. PubMed ID: 18194557 [TBL] [Abstract][Full Text] [Related]
22. Novel approaches on epigenetics. Papait R; Monti E; Bonapace IM Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872 [TBL] [Abstract][Full Text] [Related]
23. Chromatin-remodelling mechanisms in cancer. Lafon-Hughes L; Di Tomaso MV; Méndez-Acuña L; Martínez-López W Mutat Res; 2008; 658(3):191-214. PubMed ID: 18403253 [TBL] [Abstract][Full Text] [Related]
24. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230 [TBL] [Abstract][Full Text] [Related]
25. Chromatin remodelling and epigenetic features of germ cells. Kimmins S; Sassone-Corsi P Nature; 2005 Mar; 434(7033):583-9. PubMed ID: 15800613 [TBL] [Abstract][Full Text] [Related]
26. Epigenetic changes in cancer. Iacobuzio-Donahue CA Annu Rev Pathol; 2009; 4():229-49. PubMed ID: 18840073 [TBL] [Abstract][Full Text] [Related]
27. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Vaissière T; Sawan C; Herceg Z Mutat Res; 2008; 659(1-2):40-8. PubMed ID: 18407786 [TBL] [Abstract][Full Text] [Related]
28. Epigenetics: surveillance team against cancer. Klein G Nature; 2005 Mar; 434(7030):150. PubMed ID: 15758980 [No Abstract] [Full Text] [Related]
30. Issue overview: epigenetic processes in development. Greene RM; Pisano MM Birth Defects Res A Clin Mol Teratol; 2011 Aug; 91(8):649-51. PubMed ID: 21630422 [No Abstract] [Full Text] [Related]
31. [Proteins binding to methylated DNA: interpreters of the epigenetic code]. Filion G; Defossez PA Med Sci (Paris); 2004 Jan; 20(1):7-8. PubMed ID: 14770354 [No Abstract] [Full Text] [Related]
32. Epigenetic processes and cancer risk assessment. Preston RJ Mutat Res; 2007 Mar; 616(1-2):7-10. PubMed ID: 17147955 [TBL] [Abstract][Full Text] [Related]
33. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer. Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188 [TBL] [Abstract][Full Text] [Related]
34. Histone acetylation and chromatin signature in stem cell identity and cancer. Shukla V; Vaissière T; Herceg Z Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830 [TBL] [Abstract][Full Text] [Related]
35. Epigenetic regulation and nucleosome positioning in the human TATA-less IL-1 alpha promoter. van Rietschoten JG; Gal-Yam EN; Jeong S; Cortez CC; Verweij CL; Jones PA Genes Immun; 2008 Oct; 9(7):582-90. PubMed ID: 18615092 [TBL] [Abstract][Full Text] [Related]